Desvenlafaxine 72888-0144-05
- Manufacturer
- Advagen Pharma Ltd
- Dosage Form
- Tablet, Extended Release
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- January 31, 2022
- Listing Expires
- December 31, 2027
- Application
- ANDA204028
Need to source Desvenlafaxine? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Desvenlafaxine Succinate | 100 mg/1 |
Drug Class
Cytochrome P450 2D6 Inhibitors [MoA]Norepinephrine Uptake Inhibitors [MoA]Serotonin Uptake Inhibitors [MoA]
Selected Package
72888-0144-05Selected500 TABLET, EXTENDED RELEASE in 1 PACKAGE (72888-144-05)
Other packages for this product(3)
1000 TABLET, EXTENDED RELEASE in 1 PACKAGE (72888-144-00)
30 TABLET, EXTENDED RELEASE in 1 PACKAGE (72888-144-30)
90 TABLET, EXTENDED RELEASE in 1 PACKAGE (72888-144-90)